This Article Full Text Full Text (PDF) All Versions of this Article: 39/3/951    most recent STROKEAHA.107.495820v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hayakawa, K. Articles by Fujiwara, M. Search for Related Content PubMed PubMed Citation Articles by Hayakawa, K. Articles by Fujiwara, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB MINOCYCLINE Medline Plus Health Information Neurologic Diseases Related Collections Apoptosis Neuroprotectors

(Stroke. 2008;39:951.)
© 2008 American Heart Association, Inc.

Original Contributions

Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1–Inhibiting Mechanism

Kazuhide Hayakawa; Kenichi Mishima, PhD; Masanori Nozako, BS; Mai Hazekawa; Shohei Mishima; Masayuki Fujioka, PhD; Kensuke Orito, PhD; Nobuaki Egashira, PhD; Katsunori Iwasaki, PhD Michihiro Fujiwara, PhD

From the Department of Neuropharmacology (K.H., K.M., M.N., M.H., S.M., M. Fujioka, N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, and the Advanced Materials Institute (K.I., M. Fujwara), Fukuoka University, Fukuoka; and the Department of Veterinary Pharmacology (K.O.), School of Veterinary Medicine, Azabu University, Kanagawa, Japan.

Correspondence and reprint requests to Michihiro Fujiwara, PhD, Department of Neuropharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, Nanakuma 8-19-1, Fukuoka City, Fukuoka, 814-0180 Japan. E-mail mfuji{at}fukuoka-u.ac.jp

Background and Purpose— Minocycline, a semisynthetic tetracycline antibiotic, has been reported to ameliorate brain injury and inhibit microglial activation after focal cerebral ischemia. However, the cerebroprotective mechanism of minocycline remains unclear. In the present study, we investigated that mechanism of minocycline in a murine model of 4-hour middle cerebral artery (MCA) occlusion.

Methods— One day after 4-hour MCA occlusion, minocycline was administered intraperitoneally for 14 days. Neurologic scores were measured 1, 7, and 14 days after cerebral ischemia. Motor coordination was evaluated at 14 days by the rota-rod test at 10 rpm. Activated microglia and high-mobility group box1 (HMGB1), a cytokine-like mediator, were also evaluated by immunostaining and Western blotting. In addition, terminal deoxynucleotidyl transferase–mediated dUTP nick end-labeling immunostaining was carried out 14 days after cerebral ischemia.

Results— Repeated treatment with minocycline (1, 5, and 10 mg/kg) for 14 days improved neurologic score, motor coordination on the rota-rod test, and survival in a dose-dependent manner. Minocycline decreased the expression of Iba1, a marker of activated microglia, as assessed by both immunostaining and Western blotting. Moreover, minocycline decreased the activation of microglia expressing HMGB1 within the brain and also decreased both brain and plasma HMGB1 levels. Additionally, minocycline significantly decreased the number of terminal deoxynucleotidyl transferase–mediated dUTP nick end-labeling–positive cells and prevented ischemic brain atrophy 14 days after cerebral ischemia.

Conclusions— Our results suggest that minocycline inhibits activated microglia expressing HMGB1 and decreases neurologic impairment induced by cerebral ischemia. Minocycline will have a palliative action and open new therapeutic possibilities for treatment of postischemic injury via an HMGB1-inhibiting mechanism.

Key Words: cerebral ischemia • high-mobility group box1 • minocycline • microglia • neuroprotection

This article has been cited by other articles:

				J. R. Caso, O. Hurtado, M. P. Pereira, B. Garcia-Bueno, L. Menchen, L. Alou, M. L. Gomez-Lus, M. A. Moro, I. Lizasoain, and J. C. Leza Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R979 - R985. [Abstract] [Full Text] [PDF]